Cash Flow Statement
Growth Metrics

Ani Pharmaceuticals (ANIP) Other Working Capital Changes (2016 - 2026)

Ani Pharmaceuticals' Other Working Capital Changes history spans 16 years, with the latest figure at $4.5 million for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 163.44% to $4.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.0 million, a 335.98% increase, with the full-year FY2025 number at $5.0 million, up 335.98% from a year prior.
  • Other Working Capital Changes hit $4.5 million in Q4 2025 for Ani Pharmaceuticals, down from $6.5 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for ANIP hit a ceiling of $8.4 million in Q4 2023 and a floor of -$9.8 million in Q2 2025.
  • Historically, Other Working Capital Changes has averaged $629050.0 across 5 years, with a median of -$77500.0 in 2021.
  • The widest YoY moves for Other Working Capital Changes: up 415.6% in 2025, down 2219.58% in 2025.
  • Tracing ANIP's Other Working Capital Changes over 5 years: stood at $1.3 million in 2021, then surged by 163.91% to $3.4 million in 2022, then soared by 145.36% to $8.4 million in 2023, then plummeted by 79.79% to $1.7 million in 2024, then skyrocketed by 163.44% to $4.5 million in 2025.
  • Business Quant data shows Other Working Capital Changes for ANIP at $4.5 million in Q4 2025, $6.5 million in Q3 2025, and -$9.8 million in Q2 2025.